Literature DB >> 8660376

Inactivation of cholesteryl ester transfer protein by cysteine modification.

D T Connolly1, D Heuvelman, K Glenn.   

Abstract

The present studies examine the effects of various cysteine-modifying reagents on human recombinant cholesteryl ester transfer protein (CETP) activity. Dithiothreitol or other reducing agents had no effect on CETP transfer activity. Alkylating agents, including iodoacetamide and N-ethyl maleimide, also did not affect transfer activity. However, incubation of CETP with hydrophobic thiol-modifying reagents such as p-chloromercuriphenylsulfonic acid (IC50 = 0.02 microM), 4,4'-dithiodipyridine (IC50 = 0.5 microM), or 4,4'-dithiobis (phenyl azide) (IC50 = 0.5 microM) resulted in complete, time-dependent inactivation of both the cholesteryl ester and triglyceride transfer activities. Inactivation could be prevented by including dithiothreitol in the incubation. Long chain fatty acyl coenzyme A compounds were also found to be effective CETP inhibitors. The extent of inhibition was time-dependent, and proportional to the chain length of the fatty acyl portion of the molecule. These results suggest that CETP contains an essential free cysteine that resides in a hydrophobic environment within the protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660376     DOI: 10.1006/bbrc.1996.0843

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Biochemical characterization of cholesteryl ester transfer protein inhibitors.

Authors:  Mollie Ranalletta; Kathleen K Bierilo; Ying Chen; Denise Milot; Qing Chen; Elaine Tung; Caroline Houde; Nadine H Elowe; Margarita Garcia-Calvo; Gene Porter; Suzanne Eveland; Betsy Frantz-Wattley; Mike Kavana; George Addona; Peter Sinclair; Carl Sparrow; Edward A O'Neill; Ken S Koblan; Ayesha Sitlani; Brian Hubbard; Timothy S Fisher
Journal:  J Lipid Res       Date:  2010-05-10       Impact factor: 5.922

2.  Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport.

Authors:  Eric J Niesor; Christine Magg; Naoto Ogawa; Hiroshi Okamoto; Elisabeth von der Mark; Hugues Matile; Georg Schmid; Roger G Clerc; Evelyne Chaput; Denise Blum-Kaelin; Walter Huber; Ralf Thoma; Philippe Pflieger; Makoto Kakutani; Daisuke Takahashi; Gregor Dernick; Cyrille Maugeais
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

3.  Arginine-directed glycation and decreased HDL plasma concentration and functionality.

Authors:  L Godfrey; N Yamada-Fowler; J Smith; P J Thornalley; N Rabbani
Journal:  Nutr Diabetes       Date:  2014-09-01       Impact factor: 5.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.